Digital Look

Ardea Biosciences Inc. (RDEA)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

$ 31.93

Change Today:

$0.04
52 Week High: $31.95
52 Week Low: $13.63

Currency: US Dollars
Shares Issued: 37.01m
Volume: 138,094

Market Cap: $1,181.64m
RiskGrade: 402
Beta: 1.38

Latest ShareCast News

AstraZeneca buys US biotech firm Ardea Biosciences

By Benjamin Chiou

Date: Monday 23 Apr 2012

Pharmaceuticals giant AstraZeneca has announced that it has agreed to acquired California-based biotechnology company Ardea Biosciences, whose lead product 'Lesinurad' (RDEA594) is currently in Phase III development as a potential treatment for the chronic management of hyperuricaemia in patients with gout.

Read full story

News Channel

RDEA ShareCast News

No recent information was found.

RDEA Newspaper Links

No recent information was found.

RDEA Tips & Analysis

No recent information was found.

RDEA News Wires

No recent information was found.

Other RDEA News

Ardea Biosciences Reports Positive Results from ...	01-Dec-2009	PR Newswire
Ardea Biosciences to Present at the Piper Jaffra...	25-Nov-2009	PR Newswire
Ardea Biosciences Reports Recent Accomplishments...	06-Nov-2009	PR Newswire
Ardea Biosciences Presents Preclinical Anti-Infl...	07-Oct-2008	PR Newswire
Ardea Biosciences to Present at the UBS Global L...	17-Sep-2008	PR Newswire

More Ardea Biosciences Inc. other rdea news

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

RDEA Market Data

Currency	US Dollars
Share Price	$ 31.93
Change Today	$ 0.04
% Change	0.13 %
52 Week High	$31.95
52 Week Low	$13.63
Volume	138,094
Shares Issued	37.01m
Market Cap	$1,181.64m
Beta	1.38
RiskGrade	402